New Approaches for LNP Design and Microfluidic Manufacturing for Vaccines and CAR T Cell Therapy
45:00
Accelerate development by outsourcing MRNA–LNP formulations to a CDMO
1:00:07
Process & Analytical Insights for GMP Manufacturing of mRNA-Lipid Nanoparticles
23:48
CAR T Cell Therapy with a Scalable RNA Lipid Nanoparticle Platform
1:16:40
Biotech Connector: Next Generation Vaccine Formulation and Delivery
48:18
Lipid nanoparticles for RNA delivery
32:05
Spotlight Session: The Future of mRNA for Cell and Gene Therapies
58:58
Clinical and Commercial Manufacturing of mRNA Therapeutics: Opportunities and Challenges
27:02